Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | PRMT3 | O60678 | 1/20 | 0.50 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.50 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.50 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.50 |
| ▸ | PRMT8 | Q9NR22 | 1/20 | 0.50 |
| ▸ | GNAO1 | P09471 | 3/20 | 0.47 |
| ▸ | GNAI3 | P08754 | 2/20 | 0.47 |
| ▸ | GNAI1 | P63096 | 2/20 | 0.47 |
| ▸ | LTA4H | P09960 | 1/20 | 0.40 |
| ▸ | NCF1 | P14598 | 1/20 | 0.38 |
| ▸ | ACHE | P22303 | 1/20 | 0.38 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.38 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.35 |
| ▸ | ARG1 | P05089 | 1/20 | 0.33 |
| ▸ | ARG2 | P78540 | 1/20 | 0.33 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.32 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.32 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxalic Acid SCHEMBL9345651 | 0.90 | PRMT3 (0.47) | ALOX15PRMT3CARM1PRMT6PRMT1 | |
| SCHEMBL25344529 | 0.87 | ARG1 (0.43) | ALOX15PRMT3CARM1PRMT6PRMT1 | |
| SCHEMBL10064775 | 0.87 | ARG1 (0.43) | ALOX15PRMT3CARM1PRMT6PRMT1 | |
| SCHEMBL10064196 | 0.87 | ARG1 (0.43) | ALOX15PRMT3CARM1PRMT6PRMT1 | |
| SCHEMBL9332530 | 0.87 | KEAP1 (0.47) | ALOX15PRMT3CARM1PRMT6PRMT1 | |
| SCHEMBL598481 | 0.83 | ALOX15 (0.48) | ALOX15PRMT3CARM1PRMT6PRMT1 | |
| SCHEMBL13569909 | 0.81 | NCF1 (0.58) | ALOX15PRMT3CARM1PRMT6PRMT1 | |
| SCHEMBL1316226 | 0.81 | SLC18A3 (0.47) | GNAO1LTA4HACHEHRH3SLC18A3 | |
| Hydrochloric Acid SCHEMBL598795 | 0.81 | GNAO1 (0.47) | ALOX15PRMT3CARM1PRMT6PRMT1 | |
| Oxalic Acid SCHEMBL9344962 | 0.79 | CHRM3 (0.41) | PRMT3CARM1PRMT6PRMT1PRMT8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115199828-B | Corrosion-resistant metal hose for underground pipeline connection and construction method thereof | 青岛亿联建设集团股份有限公司 | 2023-08-08 | — | — | CN | claimed |
| CN-115199828-A | Corrosion-resistant metal hose for underground pipeline connection and construction method thereof | 青岛亿联建设集团股份有限公司 | 2022-10-18 | — | — | CN | claimed |
| CN-113801292-B | Water dispersion of polyurethane or polyurethane urea and preparation method thereof, water-based space leather base and preparation method thereof | 万华化学集团股份有限公司 | 2022-08-05 | — | — | CN | claimed |
| CN-113801292-A | Aqueous dispersion of polyurethane or polyurethane urea and preparation method thereof, aqueous space leather base and preparation method thereof | 万华化学集团股份有限公司 | 2021-12-17 | — | — | CN | claimed |
| US-12528948-B2 | Amino (meth)acrylates | ALLNEX BELGIUM S.A. (BE) | 2026-01-20 | — | — | US | disclosed |
| US-12084445-B2 | Broad-spectrum carbapenems | VenatoRx Pharmaceuticals, Inc. (US) | 2024-09-10 | — | — | US | disclosed |
| US-20240109917-A1 | PYRAZOLOTHIAZOLE CARBOXAMIDES AND THEIR USES AS PDGFR INHIBITORS | ACTELION PHARMACEUTICALS LTD (CH) | 2024-04-04 | — | — | US | disclosed |
| EP-4267585-A1 | PYRAZOLOTHIAZOLE CARBOXAMIDES AND THEIR USES AS PDGFR INHIBITORS | Actelion Pharmaceuticals Ltd (CH) | 2023-11-01 | — | — | EP | disclosed |
| CN-116802184-A | Pyrazolothiazole carboxamides and their use as PDGFR inhibitors | 埃科特莱茵药品有限公司 | 2023-09-22 | — | — | CN | disclosed |
| CN-115199828-B | Corrosion-resistant metal hose for underground pipeline connection and construction method thereof | 青岛亿联建设集团股份有限公司 | 2023-08-08 | — | — | CN | disclosed |
| US-20230151222-A1 | AMINO (METH)ACRYLATES | ALLNEX BELGIUM S.A. (BE) | 2023-05-18 | — | — | US | disclosed |
| WO-2023067125-A1 | OLIGOSACCHARIDE COMPLEXES AND USES | BioNTech SE (DE) | 2023-04-27 | — | — | WO | disclosed |
| EP-0885190-B1 | N-SUBSTITUTED 4-((4'-AMINOBENZOYL)-OXYMETHYL)-PIPERIDINES HAVING GASTRIC PROKINETIC PROPERTIES | JANSSEN PHARMACEUTICA NV (BE) | 2003-05-07 | — | — | EP | disclosed |
| US-6509339-B2 | Gastrointestinal disorders; cardiovascular disorders | JANSSEN PHARMACEUTICA N.V. (BE) | 2003-01-21 | — | — | US | disclosed |
| US-20020042430-A1 | Novel esters of 1, 4-disubstituted piperidine derivatives | BOSMANS JEAN-PAUL RENE MARIE (BE) | 2002-04-11 | — | — | US | disclosed |
| US-6291481-B1 | CONDITIONS RELATED TO A HAMPERED OR IMPAIRED GASTRIC EMPTYING AND MORE GENERALLY TO TREAT CONDITIONS RELATED TO A HAMPERED OR IMPAIRED GASTROINTESTINAL TRANSIT. | JANSSEN PHARMACEUTICA, N.V. (BE) | 2001-09-18 | — | — | US | disclosed |
| EP-0885190-A1 | NOVEL N-SUBSTITUTED 4-((4'-AMINOBENZOYL)-OXYMETHYL)-PIPERIDINES HAVING GASTRIC PROKINETIC PROPERTIES | JANSSEN PHARMACEUTICA N.V. (BE) | 1998-12-23 | — | — | EP | disclosed |
| WO-1997031897-A1 | NOVEL N-SUBSTITUTED 4-((4'-AMINOBENZOYL)-OXYMETHYL)-PIPERIDINES HAVING GASTRIC PROKINETIC PROPERTIES | JANSSEN PHARMACEUTICA N.V. (BE) | 1997-09-04 | — | — | WO | disclosed |
| EP-0366004-B1 | Cyclic azaaliphatic compounds with a nitroxy group, process for their preparation and pharmaceutical compositions thereof | BOEHRINGER MANNHEIM GMBH (DE) | 1994-03-30 | — | — | EP | disclosed |
| EP-0366004-A1 | Cyclic azaaliphatic compounds with a nitroxy group, process for their preparation and pharmaceutical compositions thereof | Roche Diagnostics GmbH (DE) | 1990-05-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020042430-A1 | Novel esters of 1, 4-disubstituted piperidine derivatives | CBR1, ALK, ESRRA | ALOX15 222/4885PRMT3 837/4885CARM1 614/4885 |
| US-12528948-B2 | Amino (meth)acrylates | MAT2B, MAT1A, MMAB | ALOX15 3780/4885PRMT3 109/4885CARM1 134/4885 |
| US-20240109917-A1 | PYRAZOLOTHIAZOLE CARBOXAMIDES AND THEIR USES AS PDGFR INHIBITORS | PDGFRA, PDGFRB, ABL1 | ALOX15 3144/4885PRMT3 1957/4885CARM1 2342/4885 |
| US-12084445-B2 | Broad-spectrum carbapenems | MGAM, ALPI, SI | ALOX15 2739/4885PRMT3 2805/4885CARM1 2868/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.